Antilipemic Action of Heparin^[*]

 

^* Presented at the Symposium on Heparin, Basel, Switzerland, September, 1974.

• References

• 1 Anfinsen Ch. B, Boyle E, Brown R. K. The role of heparin in lipoprotein metabolism. Science 1952; 115: 583.
• 2 Ballard K, Fredholm B. B, Meng H. C, Rosell S. Heparin-induced release of lipase activity from perfused canine subcutaneous adipose tissue. Experimental Biology and Medicine 1971; 137: 1490.
• 3 Bierman E. L, Porte Jr. D, Bagdade J. D, Hazzard W. R. Lipoprotein lipase and plasma triglyceride. In R. J. Jones (ed.). Atherosclerosis, Proceedings of the Second International Symposium. Springer, Berlin, Heidelberg; New York: 1970: 230.
• 4 Boberg J, Carlson L. A, Normell L. Production of lipolytic activity by the isolated perfused dog liver in response to heparin. Life Sciences 1964; 3: 1011.
• 5 Deutsch E. Klinische Anwendung der Anticoagulantien. In F. Maekwaedt (ed.). Handbuch der experimentellen Pharmakologie, Anticoagulantien. Vol. 27 Springer, Berlin, Heidelberg; New York: 1971: 302.
• 6 Fielding C. J. Purification of lipoprotein lipase from rat post-heparin plasma. Biochimica et Biophysica Acta (Amst.) 1969; 178: 499.
• 7 Fielding C. J. Further characterization of lipoprotein lipase and hepatic post-heparin lipase from rat plasma. Biochimica et biophysica Acta (Amst.) 1972; 280: 569.
• 8 Gastpar H. Physiologische Bedeutung und pharmakologische Wirkungen des Heparins. Thrombosis et Diathesis Haemorrhagica 1965 Suppl. 16..
• 9 Greten H, Levy R. I, Frederickson D. S. Evidence for separate mono- giyceride hydrolase and triglyceride lipase in post-heparin human plasma. Journal of Lipid Research 1969; 10: 326.
• 10 Hahn P. F. Abolishment of alimentary lipemia following injection of heparin. Science 1943; 98: 19.
• 11 Jorpes J. E. Heparin. In F. Markwardt (ed.) Handbuch der experimentellen Pharmakologie, Anticoagulantien. Vol. 27. Springer, Berlin, Heidelberg; New York: 1971: 143.
• 12 Korn E. D. Clearing factor, a heparin activated lipoprotein lipase. Journal of Biological Chemistry 1955; 215: 1.
• 13 Korn E. D. Lipoprotein lipase. In: Page I. H. : Chemistry of Lipids as Related to Atherosclerosis. Thomas, Springfield, I11 1958: 169.
• 14 Kraupp O. Der Mechanismus der Klärwirkung des Heparins. Wiener klinische Wochenschrift 1956; 68: 937.
• 15 Kurien V. A, Yates P. A, Oliver M. F. Free fatty acids, heparin, and arrhythmias during experimental myocardial infarction. Lancet 1969; II: 185.
• 16 Nordøy A, Strøm E, Berntsen H. Effect of high plasma FFA induced by heparin during alimentary hyperlipaemia on platelets. Thrombosis Research 4 Suppl. 1 71. 1974;
• 17 Payza A. N, Eiber H. B, Walter S. Studies with clearing factor. V. State of tissue lipases after injection of heparin. Proceedings of the Society for Experimental Biology 1967; 125: 188.
• 18 Porte Jr. D, Bierman E. L. The effect of heparin infusion on plasma triglyceride in vivo and in vitro with a method for calculating triglyceride turnover. Journal of Laboratory and Clinical Medicine 1969; 73: 631.
• 19 Robinson D. S. The clearing factor lipase activity of adipose tissue. In: A. E. Renold G. F. Cahill (eds.). Handbook of Physiology, Sect. 5. American Physiological Society; Washington, D. C.: 295. 1965
• 20 Robinson D. S. The role of clearing factor lipase in the removal of chylomicron triglycerides from the blood. In: G. Cowgill L. W. Kinsell (eds.). Proceedings of the 1967 Deuel Conference on Lipids on the Fate of Dietary Lipids U. S. Government Printing Office; Washington, D. C.: 1967: 166.
• 21 Schettler G. Die klinische Bedeutung der Lipoproteidlipase. In: Lipoproteid- lipase, Symposium, Wien 1962. Karger, Basel 1963: 106.
• 22 Vogel W. C, Bierman E. L. Post-heparin serum lecithinase in man and its positional specificity. Journal of Lipid Research 1967; 8: 46.
• 23 Woldow A, Chapman J. E, Evans J. M. Fat tolerance test in subjects with arteriosclerosis. Heparin effects upon lipemia lipoproteins and gamma globulin. American Heart Journal 1954; 47: 568.
• 24 Wolf R, Beck O. A, Hochrein H. Der Einfluß von Heparin auf die Häufigkeit von Rhythmusstörungen beim akuten Myokardinfarkt. Deutsche medizinische Wochenschrift 1974; 99: 1549.